Picture Berlin Partner Special Topic Well-trained Professionals 650x100px
Organisation › Details

Prothena (Group)

Prothena Corporation plc is a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding and cell adhesion, particularly on the discovery, development and commercialization of potential therapeutic monoclonal antibodies directed specifically to disease-causing proteins. These potential therapies have a broad range of indications, including AL and AA forms of amyloidosis (NEOD001), Parkinson's disease and related synucleinopathies (PRX002), and novel cell adhesion targets involved in inflammatory disease and metastatic cancers (PRX003). Prothena conducts its operations through its wholly- owned subsidiaries, Neotope Biosciences Limited, Onclave Therapeutic Limited and Prothena Biosciences Inc. *


Period Start 2012-12-21 splitoff
  Predecessor Élan Corporation, plc
Products Industry CNS drug (neurological drug)
  Industry 2 drug discovery
Persons Person Kinney, Gene G. (Prothena 201610– CEO before COO + CSO before Élan)
  Person 2 Nguyen, Tran (Prothena 201701 CFO)
Region Region Dublin
  Country Ireland, Republic of
  Street 25–28 North Wall Quay
  City Dublin 1
  Tel +353-1-902-3519
    Address record changed: 2020-12-02
Basic data Employees n. a.
  Currency USD
  Annual sales 1,055,000 (revenue, total, consolidated (2016) 2016-12-31)
  Profit -160,108,000 (2016-12-31)
  Cash 386,923,000 (2016-12-31)
    * Document for »About Section«: 
Record changed: 2023-07-10


Picture EBD Group Biotech Showcase 2024 San Francisco 650x200px

More documents for Prothena (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top